7-year-old Josh Hardy needed help. Pressure on one pharmaceutical company resulted in Josh getting the help he needed. But at what cost?
Josh Hardy has battled 4 cancers since he was 9 months old. by Google Images w/caption by Rev Dan
Today, however, that headline has changed to:
7-year-old Josh Hardy might live.
With the help of thousands of friends - via facebook and change.org - Josh may be given a new lease on life through an experimental drug previously denied to him.
Supporters of a dying 7-year-old had planned to travel to Durham Thursday to convince drug maker Chimerix to release an experimental drug that could save the boy.
"Josh's Army", numbering in the tens of thousands, responded to his dilemma last week with angry tweets and notes on Facebook, and Chimerix's executives have gotten death threats. They screamed for "compassionate use."
Here's the way it [compassionate use] works: According to the Food and Drug Administration, if someone has a serious or immediately life-threatening disease and has tried and failed other available treatments, they can ask a drug company for an experimental drug, one that they're still studying and has not yet been approved by the FDA.
The All Or Nothing Dillemma
Chimerix, the producer of the experimental drug brincidofovir, at first denied the drug because it was not yet approved by the FDA for Josh's kind of virus. That's when people started screaming "compassionate use" at Chimerix. But the company said that if they gave it to Josh, they would have to give it to the hundreds of others waiting for it - at $50,000 each - a sum that would significantly halt the research on the drug. Chimerix is not a large company - it employs only about 50 people. Not all drug companies are big, bad conglomerates, so Chimerix worked out a deal with the FDA.
Let's hope that the combined efforts of Josh, his parents, Facebook, change.org, the FDA and, yes, Chimerix produce the results everyone is hoping for.